{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:11:01Z","timestamp":1794557461614,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA137110"],"award-info":[{"award-number":["CA137110"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA161294"],"award-info":[{"award-number":["CA161294"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13058-019-1100-9","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T13:03:43Z","timestamp":1548853423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Serum erythropoietin levels, breast cancer and breast cancer-initiating cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Kruttika","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiri","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Duhachek-Muggy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda A.","family":"Moatamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara E.","family":"Magyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Vlashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Pajonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"9503","key":"1100_CR1","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087\u2013106.","journal-title":"Lancet"},{"issue":"1","key":"1100_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00066-004-1123-7","volume":"180","author":"M Henke","year":"2004","unstructured":"Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol. 2004;180(1):45\u201351.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1100_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1179\/1607845414Y.0000000161","volume":"20","author":"BL Gaspar","year":"2015","unstructured":"Gaspar BL, Sharma P, Das R. Anemia in malignancies: pathogenetic and diagnostic considerations. Hematology. 2015;20(1):18\u201325.","journal-title":"Hematology"},{"issue":"8","key":"1100_CR4","first-page":"724","volume":"83","author":"C Lacombe","year":"1998","unstructured":"Lacombe C, Mayeux P. Biology of erythropoietin. Haematologica. 1998;83(8):724\u201332.","journal-title":"Haematologica"},{"issue":"12","key":"1100_CR5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1593\/neo.07694","volume":"9","author":"TM Phillips","year":"2007","unstructured":"Phillips TM, Kim K, Vlashi E, McBride WH, Pajonk F. Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia. 2007;9(12):1122\u20139.","journal-title":"Neoplasia"},{"issue":"9","key":"1100_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100(9):672\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1100_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/1947601909356352","volume":"1","author":"Y Cao","year":"2010","unstructured":"Cao Y, Lathia JD, Eyler CE, Wu Q, Li Z, Wang H, et al. Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance. Genes Cancer. 2010;1(1):50\u201361.","journal-title":"Genes Cancer"},{"issue":"4","key":"1100_CR8","first-page":"411","volume":"33","author":"TG Eccles","year":"2003","unstructured":"Eccles TG, Patel A, Verma A, Nicholson D, Lukes Y, Tuttle RM, et al. Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator. Ann Clin Lab Sci. 2003;33(4):411\u201322.","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"1100_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/modpathol.3800288","volume":"18","author":"MO Arcasoy","year":"2005","unstructured":"Arcasoy MO, Amin K, Vollmer RT, Jiang X, Demark-Wahnefried W, Haroon ZA. Erythropoietin and erythropoietin receptor expression in human prostate cancer. Mod Pathol. 2005;18(3):421\u201330.","journal-title":"Mod Pathol"},{"issue":"9674","key":"1100_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","volume":"373","author":"J Bohlius","year":"2009","unstructured":"Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet. 2009;373(9674):1532\u201342.","journal-title":"Lancet"},{"key":"1100_CR11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","volume":"262","author":"M Henke","year":"2003","unstructured":"Henke M, Laszig R, R\u00fcbe C, Sch\u00e4fer U, Haase KD, Schilcher B, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003;262:1255\u201360.","journal-title":"Lancet"},{"issue":"8","key":"1100_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(03)01163-X","volume":"4","author":"B Leyland-Jones","year":"2003","unstructured":"Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol. 2003;4(8):459\u201360.","journal-title":"Lancet Oncol"},{"key":"1100_CR13","first-page":"1514","volume":"07","author":"JR Wright","year":"2006","unstructured":"Wright JR, Ung YC, Julian JA, Pritchard KI, Whelan TJ, Smith C, et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 2007:JCO. 2006;07:1514.","journal-title":"J Clin Oncol 2007:JCO"},{"issue":"5","key":"1100_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/jnci\/djn509","volume":"101","author":"E Vlashi","year":"2009","unstructured":"Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, et al. In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst. 2009;101(5):350\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"1100_CR15","first-page":"70","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347(1\u20132):70\u20138.","journal-title":"J Immunol Methods"},{"issue":"1","key":"1100_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/stem.1537","volume":"32","author":"C Lagadec","year":"2014","unstructured":"Lagadec C, Vlashi E, Frohnen P, Alhiyari Y, Chan M, Pajonk F. The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells. 2014;32(1):135\u201344.","journal-title":"Stem Cells"},{"issue":"4","key":"1100_CR17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bbamcr.2012.01.002","volume":"1823","author":"H Xu","year":"2012","unstructured":"Xu H, Fu J, Ha SW, Ju D, Zheng J, Li L, et al. The CCAAT box-binding transcription factor NF-Y regulates basal expression of human proteasome genes. Biochim Biophys Acta. 2012;1823(4):818\u201325.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1100_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-013-2688-6","volume":"141","author":"E Vlashi","year":"2013","unstructured":"Vlashi E, Lagadec C, Chan M, Frohnen P, McDonald AJ, Pajonk F. Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Res Treat. 2013;141(2):197\u2013203.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1100_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/stem.1058","volume":"30","author":"C Lagadec","year":"2012","unstructured":"Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells. 2012;30(5):833\u201344.","journal-title":"Stem Cells"},{"issue":"3","key":"1100_CR20","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1530\/ERC-14-0447","volume":"22","author":"W Wei","year":"2015","unstructured":"Wei W, Lewis MT. Identifying and targeting tumor-initiating cells in the treatment of breast cancer. Endocr Relat Cancer. 2015;22(3):R135\u201355.","journal-title":"Endocr Relat Cancer"},{"issue":"24","key":"1100_CR21","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/jnci\/djj495","volume":"98","author":"T Phillips","year":"2006","unstructured":"Phillips T, Mcbride W, Pajonk F. The response of CD24(\u2212\/low)\/CD44(+) breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006;98(24):1777\u201385.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1100_CR22","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/bcr2479","volume":"12","author":"C Lagadec","year":"2010","unstructured":"Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, et al. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res. 2010;12(1):R13.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1100_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1073\/pnas.0606599104","volume":"104","author":"WA Woodward","year":"2007","unstructured":"Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. WNT\/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A. 2007;104(2):618\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1100_CR24","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1100_CR25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S0301-472X(02)00868-8","volume":"30","author":"JH Myklebust","year":"2002","unstructured":"Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells. Exp Hematol. 2002;30(9):990\u20131000.","journal-title":"Exp Hematol"},{"issue":"1","key":"1100_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1078-0432.CCR-09-1630","volume":"16","author":"E Charafe-Jauffret","year":"2010","unstructured":"Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer. 2010;16(1):45\u201355.","journal-title":"Clin Cancer"},{"issue":"5","key":"1100_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555\u201367.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"1100_CR28","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","volume":"69","author":"EH Huang","year":"2009","unstructured":"Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69(8):3382\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"1100_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-009-0619-3","volume":"123","author":"E Resetkova","year":"2010","unstructured":"Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat. 2010;123(1):97\u2013108.","journal-title":"Breast Cancer Res Treat"},{"issue":"38","key":"1100_CR30","doi-asserted-by":"publisher","first-page":"16062","DOI":"10.1073\/pnas.1106704108","volume":"108","author":"E Vlashi","year":"2011","unstructured":"Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, et al. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A. 2011;108(38):16062\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1100_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2407-14-152","volume":"14","author":"C Lagadec","year":"2014","unstructured":"Lagadec C, Vlashi E, Bhuta S, Lai C, Mischel P, Werner M, et al. Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. BMC Cancer. 2014;14(1):152.","journal-title":"BMC Cancer"},{"issue":"6859","key":"1100_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105\u201311.","journal-title":"Nature"},{"issue":"18","key":"1100_CR33","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821\u20138.","journal-title":"Cancer Res"},{"issue":"7015","key":"1100_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396\u2013401.","journal-title":"Nature"},{"issue":"25","key":"1100_CR35","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.2036535100","volume":"100","author":"HD Hemmati","year":"2003","unstructured":"Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A. 2003;100(25):15178\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"1100_CR36","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","volume":"65","author":"D Fang","year":"2005","unstructured":"Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 2005;65(20):9328\u201337.","journal-title":"Cancer Res"},{"issue":"23","key":"1100_CR37","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","volume":"65","author":"AT Collins","year":"2005","unstructured":"Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65(23):10946\u201351.","journal-title":"Cancer Res"},{"issue":"7123","key":"1100_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445(7123):111\u20135.","journal-title":"Nature"},{"issue":"24","key":"1100_CR39","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1073\/pnas.0703478104","volume":"104","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007;104(24):10158\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1100_CR40","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince ME. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104:973\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1100_CR41","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"1100_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2007","unstructured":"Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2007;15(3):504\u201314.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1100_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/stem.563","volume":"29","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells. 2011;29(1):32\u201345.","journal-title":"Stem Cells"},{"issue":"2","key":"1100_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0167-8140(98)00115-7","volume":"50","author":"M Henke","year":"1999","unstructured":"Henke M, Guttenberger R, Barke A, Pajonk F, Potter R, Frommhold H. Erythropoietin for patients undergoing radiotherapy: a pilot study. Radiother Oncol. 1999;50(2):185\u201390.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1100_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.radonc.2018.02.018","volume":"127","author":"J Overgaard","year":"2018","unstructured":"Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, et al. DAHANCA 10 - effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group. Radiother Oncol. 2018;127(1):12\u20139.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1100_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/030089160208800214","volume":"88","author":"G Westphal","year":"2002","unstructured":"Westphal G, Niederberger E, Blum C, Wollman Y, Knoch TA, Rebel W, et al. Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality. Tumori. 2002;88(2):150\u20139.","journal-title":"Tumori"},{"issue":"6","key":"1100_CR47","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/bjc.1998.572","volume":"78","author":"O Thews","year":"1998","unstructured":"Thews O, Koenig R, Kelleher DK, Kutzner J, Vaupel P. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer. 1998;78(6):752\u20136.","journal-title":"Br J Cancer"},{"issue":"2","key":"1100_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1006\/gyno.1999.5368","volume":"73","author":"DF Silver","year":"1999","unstructured":"Silver DF, Piver MS. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect. Gynecol Oncol. 1999;73(2):280\u20134.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"1100_CR49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s004320000215","volume":"127","author":"G Stuben","year":"2001","unstructured":"Stuben G, Thews O, Pottgen C, Knuhmann K, Vaupel P, Stuschke M. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol. 2001;127(6):346\u201350.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"1100_CR50","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1523-1755.2000.00211.x","volume":"58","author":"C Westenfelder","year":"2000","unstructured":"Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int. 2000;58(2):647\u201357.","journal-title":"Kidney Int"},{"issue":"9","key":"1100_CR51","first-page":"3561","volume":"61","author":"G Acs","year":"2001","unstructured":"Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, et al. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res. 2001;61(9):3561\u20135.","journal-title":"Cancer Res"},{"issue":"2 Suppl 2","key":"1100_CR52","first-page":"215","volume":"106","author":"Y Yasuda","year":"2001","unstructured":"Yasuda Y, Fujita Y, Musha T, Tanaka H, Shiokawa S, Nakamatsu K, et al. Expression of erythropoietin in human female reproductive organs. Ital J Anat Embryol. 2001;106(2 Suppl 2):215\u201322.","journal-title":"Ital J Anat Embryol"},{"issue":"6","key":"1100_CR53","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1054\/bjoc.2000.1666","volume":"84","author":"Y Yasuda","year":"2001","unstructured":"Yasuda Y, Musha T, Tanaka H, Fujita Y, Fujita H, Utsumi H, et al. Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice. Br J Cancer. 2001;84(6):836\u201343.","journal-title":"Br J Cancer"},{"issue":"6","key":"1100_CR54","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/carcin\/bgg060","volume":"24","author":"Y Yasuda","year":"2003","unstructured":"Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, Tazaki A, et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis. 2003;24(6):1021\u20139.","journal-title":"Carcinogenesis"},{"issue":"12","key":"1100_CR55","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1535-7163.1525.3.12","volume":"3","author":"AI Belenkov","year":"2004","unstructured":"Belenkov AI, Shenouda G, Rizhevskaya E, Cournoyer D, Belzile JP, Souhami L, et al. Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. Mol Cancer Ther. 2004;3(12):1525\u201332.","journal-title":"Mol Cancer Ther"},{"key":"1100_CR56","doi-asserted-by":"crossref","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780-3.","DOI":"10.1038\/nature07733"},{"key":"1100_CR57","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756\u201360.","journal-title":"Nature"},{"issue":"2","key":"1100_CR58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1172\/JCI69804","volume":"124","author":"B Zhou","year":"2014","unstructured":"Zhou B, Damrauer JS, Bailey ST, Hadzic T, Jeong Y, Clark K, et al. Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. J Clin Invest. 2014;124(2):553\u201363.","journal-title":"J Clin Invest"},{"issue":"11\u201312","key":"1100_CR59","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/dta.388","volume":"3","author":"C Reichel","year":"2011","unstructured":"Reichel C. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design. Drug Test Anal. 2011;3(11\u201312):883\u201391.","journal-title":"Drug Test Anal"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-019-1100-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T04:09:06Z","timestamp":1662869346000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-019-1100-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1186\/s13058-019-1100-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"24 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by University of California Los Angeles Ethics Committee. Protocol # IRB 12-000229. Animal experiments were approved by the University of California Los Angeles Animal Research Committee. Protocol ARC #2006-082","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}